Short sellers switch to other Kosdaq-listed biotech stocks as Celltrion moves to Kospi

in celltrion •  7 years ago 

Biotech companies topped the short-selling chart of the secondary board on Feb. 8. About KRW 70.4 billion (USD 64.7 million) worth of Celltrion Healthcare shares, or about 14% of the overall transactions, were sold short on that day. Viromed, Medytox and SillaJen were also targeted by short sellers on Feb. 8 and the day after, the report said.

celltrion viromed medytox silljen
7 years ago by

Downvoting a post can decrease pending rewards and make it less visible. Common reasons:

  • Disagreement on rewards
  • Fraud or plagiarism
  • Hate speech or trolling
  • Miscategorized content or spam

Submit
$0.00
    0
    Authors get paid when people like you upvote their post.
    If you enjoyed what you read here, create your account today and start earning FREE STEEM!